<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Archiving and Interchange DTD v2.3 20070202//EN" "archivearticle.dtd"><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="EN"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Mol Vis</journal-id><journal-id journal-id-type="publisher-id">MV</journal-id><journal-title>Molecular Vision</journal-title><issn pub-type="epub">1090-0535</issn><publisher><publisher-name>Molecular Vision</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">118</article-id><article-id pub-id-type="publisher-id">2009MOLVIS0122</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title>Evaluation of <italic>PTPN22</italic> polymorphisms and Vogt-Koyanagi-Harada disease in Japanese patients</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name><surname>Horie</surname><given-names>Yukihiro</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Kitaichi</surname><given-names>Nobuyoshi</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Katsuyama</surname><given-names>Yoshihiko</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Yoshida</surname><given-names>Kazuhiko</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Miura</surname><given-names>Toshie</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ota</surname><given-names>Masao</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Asukata</surname><given-names>Yuri</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Inoko</surname><given-names>Hidetoshi</given-names></name><xref ref-type="aff" rid="aff5"><sup>5</sup></xref></contrib><contrib contrib-type="author"><name><surname>Mizuki</surname><given-names>Nobuhisa</given-names></name><xref ref-type="aff" rid="aff4"><sup>4</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ishida</surname><given-names>Susumu</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Ohno</surname><given-names>Shigeaki</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref><xref ref-type="aff" rid="aff6"><sup>6</sup></xref></contrib><aff id="aff1"><label>1</label>Department of Ophthalmology, Hokkaido University Graduate School of Medicine, Sapporo, Japan</aff><aff id="aff2"><label>2</label>Department of Pharmacy, Shinshu University School of Medicine, Matsumoto, Japan</aff><aff id="aff3"><label>3</label>Department of Legal Medicine, Shinshu University School of Medicine, Matsumoto, Japan</aff><aff id="aff4"><label>4</label>Department of Ophthalmology, Yokohama City University School of Medicine, Yokohama, Japan</aff><aff id="aff5"><label>5</label>Department of Molecular Life Science, Division of Molecular Medical Science and Molecular Medicine, Tokai University School of Medicine, Isehara, Japan</aff><aff id="aff6"><label>6</label>Department of Ocular Inflammation and Immunology, Hokkaido University Graduate School of Medicine, Sapporo, Japan</aff></contrib-group><author-notes><corresp id="cor1">Correspondence to: Yukihiro Horie, MD, Department of Ophthalmology and Visual Sciences, Hokkaido University Graduate School of Medicine, N-15, W-7, Kita-ku, Sapporo, 060-8638, Japan; Phone: +81-11-706-5944; FAX: +81-11-706-5948; email: <email xlink:href="y-horie@med.hokudai.ac.jp">y-horie@med.hokudai.ac.jp</email></corresp></author-notes><pub-date pub-type="collection"><year>2009</year></pub-date><pub-date pub-type="epub"><day>03</day><month>6</month><year>2009</year></pub-date><volume>15</volume><fpage>1115</fpage><lpage>1119</lpage><history><date date-type="received"><day>15</day><month>4</month><year>2009</year></date><date date-type="accepted"><day>29</day><month>5</month><year>2009</year></date></history><permissions><copyright-year>2009</copyright-year><copyright-holder>Molecular Vision</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/3.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.</p></license></permissions><abstract><sec><title>Purpose</title><p>Vogt-Koyanagi-Harada (VKH) disease is an autoimmune disorder against melanocytes. Polymorphisms of the protein tyrosine phosphatase non-receptor 22 gene (<italic>PTPN22</italic>) have recently been reported to be associated with susceptibility to several autoimmune diseases. In this study, genetic susceptibility to VKH disease was investigated by screening for single nucleotide polymorphisms (SNPs) of <italic>PTPN22</italic>.</p></sec><sec sec-type="methods"><title>Methods</title><p>A total of 167 Japanese patients with VKH disease and 188 healthy Japanese controls were genotyped by direct sequencing methods for six SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3811021">rs3811021</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1217413">rs1217413</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1237682">rs1237682</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3761935">rs3761935</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3789608">rs3789608</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2243471">rs2243471</ext-link>) of <italic>PTPN22</italic> including the uncoding exons.</p></sec><sec><title>Results</title><p>The six SNPs in <italic>PTPN22</italic> showed no significant association with susceptibility to VKH disease or its ocular, neurologic, or dermatological manifestation.</p></sec><sec><title>Conclusions</title><p>Further studies are needed to clarify the genetic mechanisms underlying VKH disease.</p></sec></abstract><custom-meta-wrap><custom-meta><meta-name>GalleyStatus</meta-name><meta-value>Export to XML</meta-value></custom-meta><custom-meta><meta-name>corr-author</meta-name><meta-value>Horie</meta-value></custom-meta></custom-meta-wrap></article-meta></front><body><sec sec-type="intro"><title>Introduction</title><p>Vogt-Koyanagi-Harada (VKH) disease is one of the most frequent forms of uveitis in Japan [<xref ref-type="bibr" rid="r1">1</xref>]. It is characterized as bilateral panuveitis accompanied by neurologic and skin lesions [<xref ref-type="bibr" rid="r2">2</xref>,<xref ref-type="bibr" rid="r3">3</xref>]. This disease is considered to be an autoimmune disease against melanocytes [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r5">5</xref>]. Though the etiology of VKH disease still remains unknown, genetic factors may play an important role in susceptibility as indicated by an established association between VKH disease and specific human leukocyte antigen (<italic>HLA</italic>)<italic>-DRB1</italic> alleles [<xref ref-type="bibr" rid="r6">6</xref>,<xref ref-type="bibr" rid="r7">7</xref>].</p><p>The protein tyrosine phosphatase non-receptor 22 gene (<italic>PTPN22</italic>) is located on chromosome 1p13.3-p13.1, and it encodes the lymphoid-specific phosphatase (Lyp) that is important in the negative control of T-cell activation and development [<xref ref-type="bibr" rid="r8">8</xref>-<xref ref-type="bibr" rid="r10">10</xref>]. Recently, it was reported the single nucleotide polymorphism (SNP), R620W (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2476601">rs2476601</ext-link>), in <italic>PTPN22</italic> increased susceptibility to several autoimmune diseases including rheumatoid arthritis (RA), systemic lupus erythematosus (SLE), and insulin dependent diabetes mellitus (IDDM) [<xref ref-type="bibr" rid="r11">11</xref>-<xref ref-type="bibr" rid="r15">15</xref>]. In the <italic>PTPN22</italic> risk variant (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2476601">rs2476601</ext-link>), this substitution disrupts an interaction between Lyp and the protein tyrosine kinase, Csk, and may translate biologically to a potential for &#x02018;hyperreactive&#x02019; pathogenic T-cell responses [<xref ref-type="bibr" rid="r8">8</xref>].</p><p>This R620W mutation was not observed in the Japanese population [<xref ref-type="bibr" rid="r16">16</xref>,<xref ref-type="bibr" rid="r17">17</xref>]. Therefore, in this study, we analyzed six SNPs, which belong to the same haplotype block as R620W (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2476601">rs2476601</ext-link>) in <italic>PTPN22</italic>. For the efficacy of the linkage analysis, we chose six SNPs of which minor allele frequencies were more than 15% from the database of <ext-link ext-link-type="uri" xlink:href="http://snp.ims.u-tokyo.ac.jp/">Japanese Single Nucleotide Polymorphisms</ext-link> [<xref ref-type="bibr" rid="r18">18</xref>,<xref ref-type="bibr" rid="r19">19</xref>].</p></sec><sec sec-type="methods"><title>Methods</title><p>We recruited 167 VKH (72 males and 95 females) patients and 188 healthy controls for this study. All patients and control subjects were Japanese. Patients were diagnosed according to the &#x0201c;Revised Diagnostic Criteria for VKH Disease&#x0201d; [<xref ref-type="bibr" rid="r3">3</xref>] at the Uveitis Survey Clinic of the Hokkaido University Hospital (Sapporo, Japan) and Yokohama City University Hospital (Yokohama, Japan). All patients and control subjects were informed of the study&#x02019;s purpose, and their consent obtained. The study was approved by the ethics committee from each institute participating in this study.</p><p>DNA was prepared from peripheral blood specimens using the QIAamp DNA Blood Mini Kit (Qiagen, Tokyo, Japan). Six SNPs (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3811021">rs3811021</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1217413">rs1217413</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1237682">rs1237682</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3761935">rs3761935</ext-link>, <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3789608">rs3789608</ext-link>, and <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2243471">rs2243471</ext-link>) from the <italic>PTPN22</italic> region were examined (<xref ref-type="fig" rid="f1">Figure 1</xref>). Each of the six SNPs was amplified by standard polymerase chain reactions (PCRs; <xref ref-type="table" rid="t1">Table 1</xref>). After purification using ExoSAP-IT (USB Corporation, Cleveland, OH), the PCR products were sequenced with Big Dye Terminator v3.1 (Applied Biosystems, Foster City, CA) using either sense or antisense primers (<xref ref-type="table" rid="t1">Table 1</xref>). The BigDye XTerminator Purification Kit (Applied Biosystems) was used to purify the DNA from sequencing reactions. The sequencing reactions were analyzed using an ABI3130 sequencer (Applied Biosystems).</p><fig id="f1" fig-type="figure" position="float"><label>Figure 1</label><caption><p><italic>PTPN22</italic> structure with two transcript isoforms and six SNP. Six SNP variants with minor allele frequencies 15% from the database of <ext-link ext-link-type="uri" xlink:href="http://snp.ims.u-tokyo.ac.jp/">Japanese Single Nucleotide Polymorphisms</ext-link>. The black and white areas in the exons indicate the UTR and coding region, respectively.</p></caption><graphic xlink:href="mv-v15-1115-f1"/></fig><table-wrap id="t1" position="float"><label>Table 1</label><caption><title>PCR primers for <italic>PTPN22</italic> SNPs.</title></caption><table frame="hsides" rules="groups"><col width="64" span="1"/><col width="46" span="1"/><col width="64" span="1"/><col width="219" span="1"/><col width="99" span="1"/><col width="99" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="left" scope="col" rowspan="1" colspan="1"/><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>position</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Primers</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Product size (bp)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>sequence primer</bold></th></tr></thead><tbody><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3811021">rs3811021</ext-link><hr/></td><td rowspan="2" valign="top" align="center" colspan="1">(SNP1)<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">114158186<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F: TGGGTTGCAATACAAACTGCTC<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">600<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Forward<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">R: TCAATTTGCCCTATTGGACTTC<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1217413">rs1217413</ext-link><hr/></td><td rowspan="2" valign="top" align="center" colspan="1">(SNP2)<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">114159273<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F: TTGCAGGTGTACTTGCAGCC<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">552<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Forward<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">R: TTGAAGGATTTCTGGACCGAC<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="~WRL0620.tmphttp://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1237682">rs1237682</ext-link><hr/></td><td rowspan="2" valign="top" align="center" colspan="1">(SNP3)<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">114165627<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F: AAGGAGGCACAGATTCCACAC<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">589<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Forward<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">R: TGACCATGCCAATATACCAACTG<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3761935">rs3761935</ext-link><hr/></td><td rowspan="2" valign="top" align="center" colspan="1">(SNP4)<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">114174051<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F: AAAGTTTCCGGCATGTTTCC<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">595<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Reverse<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">R: TGGTGATTGTCGGCTAAGATTG<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3789608">rs3789608</ext-link><hr/></td><td rowspan="2" valign="top" align="center" colspan="1">(SNP5)<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">114199311<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">F: CATCATGGTCTGGCCAATTC<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">589<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">Forward<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">R: TGAGGTGGAGTTCTAACCACAAG<hr/></td></tr><tr><td rowspan="2" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2243471">rs2243471</ext-link></td><td rowspan="2" valign="top" align="center" colspan="1">(SNP6)</td><td rowspan="2" valign="top" align="center" colspan="1">114207525</td><td valign="top" align="center" rowspan="1" colspan="1">F: GACAAGACTGAATTGTACGAGCG<hr/></td><td rowspan="2" valign="top" align="center" colspan="1">577</td><td rowspan="2" valign="top" align="center" colspan="1">Forward</td></tr><tr><td valign="top" colspan="1" align="center" scope="col" rowspan="1">R: CACCATCTCCAGCCTCTCAC</td></tr></tbody></table><table-wrap-foot><p>The position of the SNPs is cited from the NCBI database.</p></table-wrap-foot></table-wrap><sec><title>Statistical analysis</title><p>For statistical analyses, the Hardy&#x02013;Weinberg equilibrium was tested for each SNP among the control subjects. Genotype frequency differences between the case and control genotypes were assessed by the &#x003c7;<sup>2</sup> test. The calculation of linkage disequilibrium (LD) and pair-wise LD (D&#x02019; value) between SNPs of the <italic>PTPN22</italic> region and the haplotypes was performed with <ext-link ext-link-type="uri" xlink:href="http://www.broad.mit.edu/mpg/haploview/">Haploview</ext-link> software, version 3.32. The maximum likelihood estimates of haplotype frequencies were estimated by pairs of unphased genotypes using the expectation-maximization (EM) algorithms in the R package &#x02018;<ext-link ext-link-type="uri" xlink:href="http://mayoresearch.mayo.edu/mayo/research/schaid_lab/software.cfm">haplo.stats</ext-link>&#x02019; [<xref ref-type="bibr" rid="r20">20</xref>].</p></sec></sec><sec sec-type="results"><title>Results</title><p>Allele frequencies for the six SNPs covering the gene were in Hardy&#x02013;Weinberg equilibrium in both the patients and controls. The allelic frequency of each SNP in both groups was nearly equal, and no association was detected when compared independently (odds ratio, OR 1.14&#x02013;1.35; <xref ref-type="table" rid="t2">Table 2</xref>). Stratifying the patients by the presence of diffuse choroiditis, sunset glow fundus, nummular chorioretinal depigmented spots, neurologic auditory involvement, meningismus, tinnitus, cerebrospinal fluid pleocytosis, or integumentary findings also revealed no evidence of association in VKH disease (data not shown). We calculated pairwise D&#x02019; values for all SNP pairs in <italic>PTPN22</italic> (<xref ref-type="fig" rid="f2">Figure 2</xref>). The pairwise D&#x02019; values in the gene were nearly 1 among almost all SNP pairs, indicating the SNPs were highly associated with each other and the entire <italic>PTPN22</italic> was contained within a single LD block. Haplotype analysis predicted and revealed that <italic>PTPN22</italic> was not associated with VKH disease in this Japanese cohort (data not shown).</p><table-wrap id="t2" position="float"><label>Table 2</label><caption><title>Genotype frequencies in VKH patients and controls.</title></caption><table frame="hsides" rules="groups"><col width="61" span="1"/><col width="45" span="1"/><col width="87" span="1"/><col width="67" span="1"/><col width="94" span="1"/><col width="67" span="1"/><col width="121" span="1"/><col width="31" span="1"/><thead><tr><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>SNP</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Allele</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>VKH (n=168)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Percentage</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Control (n=187)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Percentage</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>Odds ratio (95% CI)</bold></th><th valign="top" align="center" scope="col" rowspan="1" colspan="1"><bold>p</bold></th></tr></thead><tbody><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3811021">rs3811021</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.24 (0.05&#x02013;17.47)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">56<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">33.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">35.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.58&#x02013;7.38)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.65<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">109<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">65.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">111<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.29 (0.84&#x02013;7.53)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.25<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">85<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.75 (0.51&#x02013;7.41)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.12<hr/></td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1217413">rs1217413</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">19.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.79 (0.45&#x02013;7.63)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.41<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">A/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">77<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">47.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">91<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48.9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.93 (0.61&#x02013;7.43)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.75<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">60<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">31.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.25 (0.80&#x02013;7.56)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.32<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">129<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">163<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.84 (0.62&#x02013;7.25)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.26<hr/></td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=1237682">rs1237682</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">26<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">15.5<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">33<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">18.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.83 (0.47&#x02013;7.63)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.53<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">47<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">89<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">49.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.94 (0.62&#x02013;7.34)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.77<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">59<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">35.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">31.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.20 (0.77&#x02013;7.53)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.42<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">131<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">155<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.87 (0.64&#x02013;7.24)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.37<hr/></td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3761935">rs3761935</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">10<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">5.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.33 (0.09&#x02013;12.76)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.08<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">55<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">33.3<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">67<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">35.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.90 (0.58&#x02013;7.39)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.62<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">107<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">64.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">110<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.29 (0.84&#x02013;7.54)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.25<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">87<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.75 (0.52&#x02013;7.41)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.12<hr/></td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=3789608">rs3789608</ext-link><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">T/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">9<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">4.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.24 (0.05&#x02013;17.57)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.05<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">C/T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">57<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">68<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">36.4<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.91 (0.59&#x02013;7.38)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.66<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">C/C<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">108<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">64.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">110<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.26 (0.82&#x02013;7.50)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.29<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">T<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">61<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">86<hr/></td><td valign="top" align="left" rowspan="1" colspan="1"><hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.74 (0.51&#x02013;7.41)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.11<hr/></td></tr><tr><td rowspan="4" valign="top" align="left" scope="row" colspan="1"><ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2243471">rs2243471</ext-link></td><td valign="top" align="center" rowspan="1" colspan="1">A/A<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">27<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">16.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">37<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">20.2<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.79 (0.46&#x02013;7.62)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.4<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">A/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">79<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48.8<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">88<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">48.1<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.03 (0.67&#x02013;7.36)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.9<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">G/G<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">56<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">34.6<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">58<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">31.7<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">1.14 (0.73&#x02013;7.48)<hr/></td><td valign="top" align="center" rowspan="1" colspan="1">0.57<hr/></td></tr><tr><td valign="top" colspan="1" align="center" scope="row" rowspan="1">A</td><td valign="top" align="center" rowspan="1" colspan="1">133</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">162</td><td valign="top" align="left" rowspan="1" colspan="1"/><td valign="top" align="center" rowspan="1" colspan="1">0.88 (0.65&#x02013;7.24)</td><td valign="top" align="center" rowspan="1" colspan="1">0.39</td></tr></tbody></table><table-wrap-foot><p>The above table is the genotype and allele frequencies of the VKH patients and healthy controls. There are no differences between patients and controls.</p></table-wrap-foot></table-wrap><fig id="f2" fig-type="figure" position="float"><label>Figure 2</label><caption><p>D' score for the six SNPs studied across the <italic>PTPN22</italic> haplotype. Black cells indicate that D' is greater than 0.9. Upper: patient population, lower: control population. The figure indicates that the six SNPs were in all the same haplotype block.</p></caption><graphic xlink:href="mv-v15-1115-f2"/></fig></sec><sec sec-type="discussion"><title>Discussion</title><p>In the present study, we analyzed polymorphisms of the new candidate gene, <italic>PTPN22</italic>, in Japanese patients with VKH disease. The gene encodes an important negative regulator of T cell activation [<xref ref-type="bibr" rid="r9">9</xref>]. An SNP of <italic>PTPN22</italic>, R620W (<ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/SNP/snp_ref.cgi?rs=2476601">rs2476601</ext-link>) was reported to be associated with several autoimmune diseases such as RA, SLE, and IDDM [<xref ref-type="bibr" rid="r11">11</xref>,<xref ref-type="bibr" rid="r12">12</xref>,<xref ref-type="bibr" rid="r14">14</xref>,<xref ref-type="bibr" rid="r15">15</xref>]. However, this SNP, which disrupts an interaction between Lyp and the protein tyrosine kinase, Csk, does not exist as a polymorphism in the Japanese population [<xref ref-type="bibr" rid="r9">9</xref>,<xref ref-type="bibr" rid="r10">10</xref>,<xref ref-type="bibr" rid="r12">12</xref>]. Therefore, in this study, we examined six other SNPs to evaluate the susceptibility locus of <italic>PTPN22</italic>. <italic>HLA-DRB1</italic> is a common genetic factor in autoimmune diseases (RA and IDDM). Therefore, there may be other common genetic factors in VKH disease [<xref ref-type="bibr" rid="r21">21</xref>].</p><p>VKH disease is considered to be an autoimmune disease against melanocytes [<xref ref-type="bibr" rid="r2">2</xref>-<xref ref-type="bibr" rid="r5">5</xref>]. In early studies, activated T lymphocytes were elevated and attacked melanocytes of ocular choroidal tissue in patients in the active phase of VKH disease [<xref ref-type="bibr" rid="r22">22</xref>]. Antigen-specific T-cell assay revealed that peptide fragments of the tyrosinase family proteins (tyrosinase, tyrosinase related protein 1 and 2) proliferated in T lymphocytes collected from VKH patients [<xref ref-type="bibr" rid="r4">4</xref>,<xref ref-type="bibr" rid="r5">5</xref>]. These proteins are found in human melanocytes. These antigen-specific T cell responses were detected in cells collected from <italic>HLA-DRB1*04</italic> positive VKH patients only but not from <italic>HLA-DRB1*04</italic> negative patients or <italic>HLA-DRB1*04</italic> positive healthy people [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r23">23</xref>]. In the Japanese population, 40% of healthy people have <italic>HLA-DRB1*04</italic> [<xref ref-type="bibr" rid="r7">7</xref>]. However, people having VKH disease represent only 0.01% of the Japanese population [<xref ref-type="bibr" rid="r1">1</xref>,<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r24">24</xref>,<xref ref-type="bibr" rid="r25">25</xref>]. In addition, some patients with VKH disease are <italic>HLA-DRB1*04</italic> negative [<xref ref-type="bibr" rid="r7">7</xref>]. Thus, it is believed <italic>HLA-DRB1*04</italic> is a major susceptible gene in VKH disease. However, other minor genetic factors still remain unclear. To find other susceptible genes, we studied the tyrosinase gene (<italic>TYR</italic>), tyrosinase related protein 1 gene (<italic>TYRP1</italic>), tyrosinase related protein 2 gene (<italic>TYRP2</italic>), and interferon (<italic>IFN-&#x003b3;</italic>), but we could not find any association with these genes and VKH disease [<xref ref-type="bibr" rid="r7">7</xref>,<xref ref-type="bibr" rid="r26">26</xref>]. Genetic influences of VKH were also investigated in other countries, but the etiology of the disease seems to be unresolved [<xref ref-type="bibr" rid="r27">27</xref>-<xref ref-type="bibr" rid="r29">29</xref>].</p><p>In this study, we found no association between <italic>PTPN22</italic> and VKH disease in the individuals studied. Our results suggest that further molecular genetic studies are needed to detect novel genetic loci and predisposing genes and to elucidate the true genetic mechanisms underlying VKH disease.</p></sec></body><back><ack><title>Acknowledgments</title><p>This work was supported by Grant-in-Aid for Scientific Research (Category B, No. 19406028) from the Ministry of Education, Culture, Science, Sports and Technology (MEXT), Japan.</p></ack><ref-list><title>References</title><ref id="r1"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goto</surname><given-names>H</given-names></name><name><surname>Mochizuki</surname><given-names>M</given-names></name><name><surname>Yamaki</surname><given-names>K</given-names></name><name><surname>Kotake</surname><given-names>S</given-names></name><name><surname>Usui</surname><given-names>M</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name></person-group><article-title>Epidemiological survey of intraocular inflammation in Japan.</article-title><source>Jpn J Ophthalmol</source><year>2007</year><volume>51</volume><fpage>41</fpage><lpage>4</lpage><pub-id pub-id-type="pmid">17295139</pub-id></citation></ref><ref id="r2"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kitamura</surname><given-names>M</given-names></name><name><surname>Takami</surname><given-names>K</given-names></name><name><surname>Kitaichi</surname><given-names>N</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Kitamei</surname><given-names>H</given-names></name><name><surname>Kotake</surname><given-names>S</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name></person-group><article-title>Comparative study of two sets of criteria for the diagnosis of Vogt-Koyanagi-Harada's disease.</article-title><source>Am J Ophthalmol</source><year>2005</year><volume>139</volume><fpage>1080</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">15953440</pub-id></citation></ref><ref id="r3"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Read</surname><given-names>RW</given-names></name><name><surname>Holland</surname><given-names>GN</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name><name><surname>Tabbara</surname><given-names>KF</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Arellanes-Garcia</surname><given-names>L</given-names></name><name><surname>Pivetti-Pezzi</surname><given-names>P</given-names></name><name><surname>Tessler</surname><given-names>HH</given-names></name><name><surname>Usui</surname><given-names>M</given-names></name></person-group><article-title>Revised diagnostic criteria for Vogt-Koyanagi-Harada disease: report of an international committee on nomenclature.</article-title><source>Am J Ophthalmol</source><year>2001</year><volume>131</volume><fpage>647</fpage><lpage>52</lpage><pub-id pub-id-type="pmid">11336942</pub-id></citation></ref><ref id="r4"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaki</surname><given-names>K</given-names></name><name><surname>Gocho</surname><given-names>K</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name><name><surname>Kondo</surname><given-names>I</given-names></name><name><surname>Sakuragi</surname><given-names>S</given-names></name></person-group><article-title>Tyrosinase family proteins are antigens specific to Vogt-Koyanagi-Harada disease.</article-title><source>J Immunol</source><year>2000</year><volume>165</volume><fpage>7323</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11120868</pub-id></citation></ref><ref id="r5"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Yamaki</surname><given-names>K</given-names></name><name><surname>Takiyama</surname><given-names>N</given-names></name><name><surname>Itho</surname><given-names>N</given-names></name><name><surname>Mizuki</surname><given-names>N</given-names></name><name><surname>Seiya</surname><given-names>M</given-names></name><name><surname>Sinsuke</surname><given-names>W</given-names></name><name><surname>Hayakawa</surname><given-names>K</given-names></name><name><surname>Kotani</surname><given-names>T</given-names></name></person-group><article-title>Experimentally induced Vogt-Koyanagi-Harada disease in two Akita dogs.</article-title><source>Exp Eye Res</source><year>2005</year><volume>80</volume><fpage>273</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">15670805</pub-id></citation></ref><ref id="r6"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Islam</surname><given-names>SM</given-names></name><name><surname>Numaga</surname><given-names>J</given-names></name><name><surname>Fujino</surname><given-names>Y</given-names></name><name><surname>Hirata</surname><given-names>R</given-names></name><name><surname>Matsuki</surname><given-names>K</given-names></name><name><surname>Maeda</surname><given-names>H</given-names></name><name><surname>Masuda</surname><given-names>K</given-names></name></person-group><article-title>HLA class II genes in Vogt-Koyanagi-Harada disease.</article-title><source>Invest Ophthalmol Vis Sci</source><year>1994</year><volume>35</volume><fpage>3890</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7928186</pub-id></citation></ref><ref id="r7"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>Y</given-names></name><name><surname>Takemoto</surname><given-names>Y</given-names></name><name><surname>Miyazaki</surname><given-names>A</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Kase</surname><given-names>S</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Hasumi</surname><given-names>Y</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Mizuki</surname><given-names>N</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name></person-group><article-title>Tyrosinase gene family and Vogt-Koyanagi-Harada disease in Japanese patients.</article-title><source>Mol Vis</source><year>2006</year><volume>12</volume><fpage>1601</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">17200659</pub-id></citation></ref><ref id="r8"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Musumeci</surname><given-names>L</given-names></name><name><surname>Alonso</surname><given-names>A</given-names></name><name><surname>Rahmouni</surname><given-names>S</given-names></name><name><surname>Nika</surname><given-names>K</given-names></name><name><surname>Rostamkhani</surname><given-names>M</given-names></name><name><surname>MacMurray</surname><given-names>J</given-names></name><name><surname>Meloni</surname><given-names>GF</given-names></name><name><surname>Lucarelli</surname><given-names>P</given-names></name><name><surname>Pellecchia</surname><given-names>M</given-names></name><name><surname>Eisenbarth</surname><given-names>GS</given-names></name><name><surname>Comings</surname><given-names>D</given-names></name><name><surname>Mustelin</surname><given-names>T</given-names></name></person-group><article-title>A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes.</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>337</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15004560</pub-id></citation></ref><ref id="r9"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siminovitch</surname><given-names>KA</given-names></name></person-group><article-title>PTPN22 and autoimmune disease.</article-title><source>Nat Genet</source><year>2004</year><volume>36</volume><fpage>1248</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">15565104</pub-id></citation></ref><ref id="r10"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gregersen</surname><given-names>PK</given-names></name></person-group><article-title>Gaining insight into PTPN22 and autoimmunity.</article-title><source>Nat Genet</source><year>2005</year><volume>37</volume><fpage>1300</fpage><lpage>2</lpage><pub-id pub-id-type="pmid">16314859</pub-id></citation></ref><ref id="r11"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Begovich</surname><given-names>AB</given-names></name><name><surname>Carlton</surname><given-names>VE</given-names></name><name><surname>Honigberg</surname><given-names>LA</given-names></name><name><surname>Schrodi</surname><given-names>SJ</given-names></name><name><surname>Chokkalingam</surname><given-names>AP</given-names></name><name><surname>Alexander</surname><given-names>HC</given-names></name><name><surname>Ardlie</surname><given-names>KG</given-names></name><name><surname>Huang</surname><given-names>Q</given-names></name><name><surname>Smith</surname><given-names>AM</given-names></name><name><surname>Spoerke</surname><given-names>JM</given-names></name><name><surname>Conn</surname><given-names>MT</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Chang</surname><given-names>SY</given-names></name><name><surname>Saiki</surname><given-names>RK</given-names></name><name><surname>Catanese</surname><given-names>JJ</given-names></name><name><surname>Leong</surname><given-names>DU</given-names></name><name><surname>Garcia</surname><given-names>VE</given-names></name><name><surname>McAllister</surname><given-names>LB</given-names></name><name><surname>Jeffery</surname><given-names>DA</given-names></name><name><surname>Lee</surname><given-names>AT</given-names></name><name><surname>Batliwalla</surname><given-names>F</given-names></name><name><surname>Remmers</surname><given-names>E</given-names></name><name><surname>Criswell</surname><given-names>LA</given-names></name><name><surname>Seldin</surname><given-names>MF</given-names></name><name><surname>Kastner</surname><given-names>DL</given-names></name><name><surname>Amos</surname><given-names>CI</given-names></name><name><surname>Sninsky</surname><given-names>JJ</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name></person-group><article-title>A missense single-nucleotide polymorphism in a gene encoding a protein tyrosine phosphatase (PTPN22) is associated with rheumatoid arthritis.</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>330</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15208781</pub-id></citation></ref><ref id="r12"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kyogoku</surname><given-names>C</given-names></name><name><surname>Langefeld</surname><given-names>CD</given-names></name><name><surname>Ortmann</surname><given-names>WA</given-names></name><name><surname>Lee</surname><given-names>A</given-names></name><name><surname>Selby</surname><given-names>S</given-names></name><name><surname>Carlton</surname><given-names>VE</given-names></name><name><surname>Chang</surname><given-names>M</given-names></name><name><surname>Ramos</surname><given-names>P</given-names></name><name><surname>Baechler</surname><given-names>EC</given-names></name><name><surname>Batliwalla</surname><given-names>FM</given-names></name><name><surname>Novitzke</surname><given-names>J</given-names></name><name><surname>Williams</surname><given-names>AH</given-names></name><name><surname>Gillett</surname><given-names>C</given-names></name><name><surname>Rodine</surname><given-names>P</given-names></name><name><surname>Graham</surname><given-names>RR</given-names></name><name><surname>Ardlie</surname><given-names>KG</given-names></name><name><surname>Gaffney</surname><given-names>PM</given-names></name><name><surname>Moser</surname><given-names>KL</given-names></name><name><surname>Petri</surname><given-names>M</given-names></name><name><surname>Begovich</surname><given-names>AB</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name><name><surname>Behrens</surname><given-names>TW</given-names></name></person-group><article-title>Genetic association of the R620W polymorphism of protein tyrosine phosphatase PTPN22 with human SLE.</article-title><source>Am J Hum Genet</source><year>2004</year><volume>75</volume><fpage>504</fpage><lpage>7</lpage><pub-id pub-id-type="pmid">15273934</pub-id></citation></ref><ref id="r13"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Michou</surname><given-names>L</given-names></name><name><surname>Lasbleiz</surname><given-names>S</given-names></name><name><surname>Rat</surname><given-names>AC</given-names></name><name><surname>Migliorini</surname><given-names>P</given-names></name><name><surname>Balsa</surname><given-names>A</given-names></name><name><surname>Westhovens</surname><given-names>R</given-names></name><name><surname>Barrera</surname><given-names>P</given-names></name><name><surname>Alves</surname><given-names>H</given-names></name><name><surname>Pierlot</surname><given-names>C</given-names></name><name><surname>Glikmans</surname><given-names>E</given-names></name><name><surname>Garnier</surname><given-names>S</given-names></name><name><surname>Dausset</surname><given-names>J</given-names></name><name><surname>Vaz</surname><given-names>C</given-names></name><name><surname>Fernandes</surname><given-names>M</given-names></name><name><surname>Petit-Teixeira</surname><given-names>E</given-names></name><name><surname>Lemaire</surname><given-names>I</given-names></name><name><surname>Pascual-Salcedo</surname><given-names>D</given-names></name><name><surname>Bombardieri</surname><given-names>S</given-names></name><name><surname>Dequeker</surname><given-names>J</given-names></name><name><surname>Radstake</surname><given-names>TR</given-names></name><name><surname>Van Riel</surname><given-names>P</given-names></name><name><surname>van de Putte</surname><given-names>L</given-names></name><name><surname>Lopes-Vaz</surname><given-names>A</given-names></name><name><surname>Prum</surname><given-names>B</given-names></name><name><surname>Bardin</surname><given-names>T</given-names></name><name><surname>Dieude</surname><given-names>P</given-names></name><name><surname>Cornelis</surname><given-names>F</given-names></name></person-group><article-title>Linkage proof for PTPN22, a rheumatoid arthritis susceptibility gene and a human autoimmunity gene.</article-title><source>Proc Natl Acad Sci USA</source><year>2007</year><volume>104</volume><fpage>1649</fpage><lpage>54</lpage><pub-id pub-id-type="pmid">17237219</pub-id></citation></ref><ref id="r14"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Criswell</surname><given-names>LA</given-names></name><name><surname>Pfeiffer</surname><given-names>KA</given-names></name><name><surname>Lum</surname><given-names>RF</given-names></name><name><surname>Gonzales</surname><given-names>B</given-names></name><name><surname>Novitzke</surname><given-names>J</given-names></name><name><surname>Kern</surname><given-names>M</given-names></name><name><surname>Moser</surname><given-names>KL</given-names></name><name><surname>Begovich</surname><given-names>AB</given-names></name><name><surname>Carlton</surname><given-names>VE</given-names></name><name><surname>Li</surname><given-names>W</given-names></name><name><surname>Lee</surname><given-names>AT</given-names></name><name><surname>Ortmann</surname><given-names>W</given-names></name><name><surname>Behrens</surname><given-names>TW</given-names></name><name><surname>Gregersen</surname><given-names>PK</given-names></name></person-group><article-title>Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes.</article-title><source>Am J Hum Genet</source><year>2005</year><volume>76</volume><fpage>561</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">15719322</pub-id></citation></ref><ref id="r15"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname><given-names>H</given-names></name><name><surname>Cantor</surname><given-names>RM</given-names></name><name><surname>Graham</surname><given-names>DS</given-names></name><name><surname>Lingren</surname><given-names>CM</given-names></name><name><surname>Farwell</surname><given-names>L</given-names></name><name><surname>Jager</surname><given-names>PL</given-names></name><name><surname>Bottini</surname><given-names>N</given-names></name><name><surname>Grossman</surname><given-names>JM</given-names></name><name><surname>Wallace</surname><given-names>DJ</given-names></name><name><surname>Hahn</surname><given-names>BH</given-names></name><name><surname>Julkunen</surname><given-names>H</given-names></name><name><surname>Hebert</surname><given-names>LA</given-names></name><name><surname>Rovin</surname><given-names>BH</given-names></name><name><surname>Birmingham</surname><given-names>DJ</given-names></name><name><surname>Rioux</surname><given-names>JD</given-names></name><name><surname>Yu</surname><given-names>CY</given-names></name><name><surname>Kere</surname><given-names>J</given-names></name><name><surname>Vyse</surname><given-names>TJ</given-names></name><name><surname>Tsao</surname><given-names>BP</given-names></name></person-group><article-title>Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease.</article-title><source>Arthritis Rheum</source><year>2005</year><volume>52</volume><fpage>2396</fpage><lpage>402</lpage><pub-id pub-id-type="pmid">16052563</pub-id></citation></ref><ref id="r16"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ichimura</surname><given-names>M</given-names></name><name><surname>Kaku</surname><given-names>H</given-names></name><name><surname>Fukutani</surname><given-names>T</given-names></name><name><surname>Koga</surname><given-names>H</given-names></name><name><surname>Mukai</surname><given-names>T</given-names></name><name><surname>Miyake</surname><given-names>I</given-names></name><name><surname>Yamada</surname><given-names>K</given-names></name><name><surname>Koda</surname><given-names>Y</given-names></name><name><surname>Hiromatsu</surname><given-names>Y</given-names></name></person-group><article-title>Associations of protein tyrosine phosphatase nonreceptor 22 (PTPN22) gene polymorphisms with susceptibility to Graves' disease in a Japanese population.</article-title><source>Thyroid</source><year>2008</year><volume>18</volume><fpage>625</fpage><lpage>30</lpage><pub-id pub-id-type="pmid">18578611</pub-id></citation></ref><ref id="r17"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ikari</surname><given-names>K</given-names></name><name><surname>Momohara</surname><given-names>S</given-names></name><name><surname>Inoue</surname><given-names>E</given-names></name><name><surname>Tomatsu</surname><given-names>T</given-names></name><name><surname>Hara</surname><given-names>M</given-names></name><name><surname>Yamanaka</surname><given-names>H</given-names></name><name><surname>Kamatani</surname><given-names>N</given-names></name></person-group><article-title>Haplotype analysis revealed no association between the PTPN22 gene and RA in a Japanese population.</article-title><source>Rheumatology (Oxford)</source><year>2006</year><volume>45</volume><fpage>1345</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">16690758</pub-id></citation></ref><ref id="r18"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hirakawa</surname><given-names>M</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name><name><surname>Hashimoto</surname><given-names>Y</given-names></name><name><surname>Kuroda</surname><given-names>M</given-names></name><name><surname>Takagi</surname><given-names>T</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name></person-group><article-title>JSNP: a database of common gene variations in the Japanese population.</article-title><source>Nucleic Acids Res</source><year>2002</year><volume>30</volume><fpage>158</fpage><lpage>62</lpage><pub-id pub-id-type="pmid">11752280</pub-id></citation></ref><ref id="r19"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Haga</surname><given-names>H</given-names></name><name><surname>Yamada</surname><given-names>R</given-names></name><name><surname>Ohnishi</surname><given-names>Y</given-names></name><name><surname>Nakamura</surname><given-names>Y</given-names></name><name><surname>Tanaka</surname><given-names>T</given-names></name></person-group><article-title>Gene-based SNP discovery as part of the Japanese Millennium Genome Project: identification of 190,562 genetic variations in the human genome. Single-nucleotide polymorphism.</article-title><source>J Hum Genet</source><year>2002</year><volume>47</volume><fpage>605</fpage><lpage>10</lpage><pub-id pub-id-type="pmid">12436197</pub-id></citation></ref><ref id="r20"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Schaid</surname><given-names>DJ</given-names></name><name><surname>Rowland</surname><given-names>CM</given-names></name><name><surname>Tines</surname><given-names>DE</given-names></name><name><surname>Jacobson</surname><given-names>RM</given-names></name><name><surname>Poland</surname><given-names>GA</given-names></name></person-group><article-title>Score tests for association between traits and haplotypes when linkage phase is ambiguous.</article-title><source>Am J Hum Genet</source><year>2002</year><volume>70</volume><fpage>425</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">11791212</pub-id></citation></ref><ref id="r21"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stastny</surname><given-names>P</given-names></name></person-group><article-title>Association of the B-cell alloantigen DRw4 with rheumatoid arthritis.</article-title><source>N Engl J Med</source><year>1978</year><volume>298</volume><fpage>869</fpage><lpage>71</lpage><pub-id pub-id-type="pmid">147420</pub-id></citation></ref><ref id="r22"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Moorthy</surname><given-names>RS</given-names></name><name><surname>Inomata</surname><given-names>H</given-names></name><name><surname>Rao</surname><given-names>NA</given-names></name></person-group><article-title>Vogt-Koyanagi-Harada syndrome.</article-title><source>Surv Ophthalmol</source><year>1995</year><volume>39</volume><fpage>265</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">7725227</pub-id></citation></ref><ref id="r23"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Shindo</surname><given-names>Y</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Yamamoto</surname><given-names>T</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name></person-group><article-title>HLA-DRB1 typing of Vogt-Koyanagi-Harada's disease by PCR-RFLP and the strong association with DRB1*0405 and DRB1*0410.</article-title><source>Br J Ophthalmol</source><year>1994</year><volume>78</volume><fpage>223</fpage><lpage>6</lpage><pub-id pub-id-type="pmid">7908535</pub-id></citation></ref><ref id="r24"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ohno</surname><given-names>S</given-names></name><name><surname>Nakamura</surname><given-names>S</given-names></name><name><surname>Hori</surname><given-names>S</given-names></name><name><surname>Shimakawa</surname><given-names>M</given-names></name><name><surname>Kawashima</surname><given-names>H</given-names></name><name><surname>Mochizuki</surname><given-names>M</given-names></name><name><surname>Sugita</surname><given-names>S</given-names></name><name><surname>Ueno</surname><given-names>S</given-names></name><name><surname>Yoshizaki</surname><given-names>K</given-names></name><name><surname>Inaba</surname><given-names>G</given-names></name></person-group><article-title>Efficacy, safety, and pharmacokinetics of multiple administration of infliximab in Behcet's disease with refractory uveoretinitis.</article-title><source>J Rheumatol</source><year>2004</year><volume>31</volume><fpage>1362</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">15229958</pub-id></citation></ref><ref id="r25"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saito</surname><given-names>S</given-names></name><name><surname>Ota</surname><given-names>S</given-names></name><name><surname>Yamada</surname><given-names>E</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name></person-group><article-title>Allele frequencies and haplotypic associations defined by allelic DNA typing at HLA class I and class II loci in the Japanese population.</article-title><source>Tissue Antigens</source><year>2000</year><volume>56</volume><fpage>522</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">11169242</pub-id></citation></ref><ref id="r26"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Horie</surname><given-names>Y</given-names></name><name><surname>Kitaichi</surname><given-names>N</given-names></name><name><surname>Takemoto</surname><given-names>Y</given-names></name><name><surname>Namba</surname><given-names>K</given-names></name><name><surname>Yoshida</surname><given-names>K</given-names></name><name><surname>Hirose</surname><given-names>S</given-names></name><name><surname>Hasumi</surname><given-names>Y</given-names></name><name><surname>Ota</surname><given-names>M</given-names></name><name><surname>Inoko</surname><given-names>H</given-names></name><name><surname>Mizuki</surname><given-names>N</given-names></name><name><surname>Ohno</surname><given-names>S</given-names></name></person-group><article-title>Polymorphism of IFN-gamma gene and Vogt-Koyanagi-Harada disease.</article-title><source>Mol Vis</source><year>2007</year><volume>13</volume><fpage>2334</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18199975</pub-id></citation></ref><ref id="r27"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Huang</surname><given-names>X</given-names></name><name><surname>Wang</surname><given-names>L</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><article-title>Association of the CTLA-4 gene with Vogt-Koyanagi-Harada syndrome.</article-title><source>Clin Immunol</source><year>2008</year><volume>127</volume><fpage>43</fpage><lpage>8</lpage><pub-id pub-id-type="pmid">18282809</pub-id></citation></ref><ref id="r28"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Lin</surname><given-names>X</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><article-title>Small ubiquitin-like modifier 4 (SUMO4) polymorphisms and Vogt-Koyanagi-Harada (VKH) syndrome in the Chinese Han population.</article-title><source>Mol Vis</source><year>2008</year><volume>14</volume><fpage>2597</fpage><lpage>603</lpage><pub-id pub-id-type="pmid">19122825</pub-id></citation></ref><ref id="r29"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Meng</surname><given-names>Q</given-names></name><name><surname>Liu</surname><given-names>X</given-names></name><name><surname>Yang</surname><given-names>P</given-names></name><name><surname>Hou</surname><given-names>S</given-names></name><name><surname>Du</surname><given-names>L</given-names></name><name><surname>Zhou</surname><given-names>H</given-names></name><name><surname>Kijlstra</surname><given-names>A</given-names></name></person-group><article-title>PDCD1 genes may protect against extraocular manifestations in Chinese Han patients with Vogt-Koyanagi-Harada syndrome.</article-title><source>Mol Vis</source><year>2009</year><volume>15</volume><fpage>386</fpage><lpage>92</lpage><pub-id pub-id-type="pmid">19234630</pub-id></citation></ref></ref-list></back></article> 